ADOPTIVE IMMUNOTHERAPY OF PRIMARY AND METASTATIC LIVER-CANCER VIA HEPATIC-ARTERY CATHETER

被引：11

作者：

MATSUHASHI, N

MORIYAMA, T

NAKAMURA, I

ISHIKAWA, T

OHNISHI, S

NAKAGAMA, H

IMAWARI, M

TAKAKU, F

机构：

来源：

EUROPEAN JOURNAL OF CANCER | 1990年 / 26卷 / 10期

关键词：

D O I：

10.1016/0277-5379(90)90065-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1106 / 1107

页数：2

共 9 条

[1]

EBERLEIN TJ, 1982, CANCER IMMUNOL IMMUN, V13, P5

[2]

ETTINGHAUSEN SE, 1986, CANCER RES, V46, P2784

[3] IMMUNOTHERAPY OF HEPATOCELLULAR-CARCINOMA WITH AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND OR RECOMBINANT INTERLEUKIN-2 [J].

ISHIKAWA, T ;

IMAWARI, M ;

MORIYAMA, T ;

OHNISHI, S ;

MATSUHASHI, N ;

SUZUKI, G ;

TAKAKU, F .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (03) :283-290

[4] CYCLOPHOSPHAMIDE-FACILITATED ADOPTIVE IMMUNOTHERAPY OF AN ESTABLISHED TUMOR DEPENDS ON ELIMINATION OF TUMOR-INDUCED SUPPRESSOR T-CELLS [J].

NORTH, RJ .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :1063-1074

[5]

OKUNO K, 1986, CANCER, V58, P1001, DOI 10.1002/1097-0142(19860901)58:5<1001::AID-CNCR2820580502>3.0.CO

[6]

2-K

[7] A PROGRESS REPORT ON THE TREATMENT OF 157 PATIENTS WITH ADVANCED CANCER USING LYMPHOKINE-ACTIVATED KILLER-CELLS AND INTERLEUKIN-2 OR HIGH-DOSE INTERLEUKIN-2 ALONE [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

CHANG, AE ;

AVIS, FP ;

LEITMAN, S ;

LINEHAN, WM ;

ROBERTSON, CN ;

LEE, RE ;

RUBIN, JT ;

SEIPP, CA ;

SIMPSON, CG ;

WHITE, DE .

NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (15) :889-897

[8] OBSERVATIONS ON THE SYSTEMIC ADMINISTRATION OF AUTOLOGOUS LYMPHOKINE-ACTIVATED KILLER CELLS AND RECOMBINANT INTERLEUKIN-2 TO PATIENTS WITH METASTATIC CANCER [J].

ROSENBERG, SA ;

LOTZE, MT ;

MUUL, LM ;

LEITMAN, S ;

CHANG, AE ;

ETTINGHAUSEN, SE ;

MATORY, YL ;

SKIBBER, JM ;

SHILONI, E ;

VETTO, JT ;

SEIPP, CA ;

SIMPSON, C ;

REICHERT, CM .

NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (23) :1485-1492

[9]

WEST WH, 1987, NEW ENGL J MED, V316, P895

← 1 →